Diamedica Therapeutics shares owned by Paragon Associates & Paragon Associates Ii Joint Venture
Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Paragon Associates & Paragon Associates Ii Joint Venture
from 13F filings
Historical chart of Paragon Associates & Paragon Associates Ii Joint Venture investment in Diamedica Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Diamedica Therapeutics held by Paragon Associates & Paragon Associates Ii Joint Venture consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Diamedica Therapeutics by Paragon Associates & Paragon Associates Ii Joint Venture
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.4M | 483k | 2.95 |
| 2024-03-31 | $1.4M | 500k | 2.77 |
| 2023-12-31 | $1.4M | 500k | 2.84 |
| 2023-09-30 | $1.2M | 470k | 2.58 |
| 2023-06-30 | $1.4M | 325k | 4.32 |
More positions owned by Paragon Associates & Paragon Associates Ii Joint Venture
View all positions for Paragon Associates & Paragon Associates Ii Joint Venture